MHRA launches campaign to promote reporting of suspected side effects from OTC medicines

A social media campaign has been launched by the Medicines Healthcare products Regulatory Agency (MHRA) to promote reporting of suspected side effects from over-the-counter (OTC) medicines. The campaign is part of an EU-wide awareness week, which runs from the 20th-24th November.

Whilst OTC medicines are generally safe and effective, side effects can still occur. Therefore it is important that any risks with a medicine are understood and communicated to health professionals and patients. Reporting any suspected side effects helps regulators monitor medicines on the market and take action when is necessary to ensure medicines are safe.

Mick Foy, Group Manager for MHRA’s Vigilance and Risk Management of Medicines division, said

  • “The most important part of our work is making sure the medicines you and your family take are effective and acceptably safe.”
  • “Our campaign will help the public, patients and healthcare professionals report potential side effects and have confidence that their reports are making a difference.”
  • “You can help make medicines safer by reporting any suspected side effects easily and quickly online through the Yellow Card Scheme.”

The main aim is to increase awareness of national reporting systems for suspected side effects in medicines. The campaign runs alongside the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action project.

Currently all reporting systems suffer from under reporting, hence this campaign is important to raise awareness and help heighten the system.

To read more about the campaign, please click here.

To report a suspected side effect, please click here.